Chlorotrimethylsilane → HCID 23349506, compound
Reaction equation
[F:1][C:2]([F:23])([F:22])[C:3]1[CH:4]=[CH:5][C:6]2[N:12]([CH3:13])[C:11](=[O:14])[CH2:10][N:9]=[C:8]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[C:7]=2[CH:21]=1.[CH3:24][Si:25]([CH3:28])([CH3:27])Cl>>[F:23][C:2]([F:1])([F:22])[C:3]1[CH:4]=[CH:5][C:6]2[N:12]([CH3:13])[C:11]([O:14][Si:25]([CH3:28])([CH3:27])[CH3:24])=[CH:10][N:9]=[C:8]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[C:7]=2[CH:21]=1Participants
3
Procedure
Following the general procedure of Part A, 2.4 g of 7-trifluoromethyl-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one was reacted with trimethylchlorosilane. The filtrate was evaporated, the residue was dissolved in CFCl3 and the CFCl3 was removed by evaporation to give 7-trifluoromethyl-1-methyl-5-phenyl-2-trimethylsiloxy-1H-1,4-benzodiazepin which was again dissolved in CFCl3 and reacted with trifluoromethyl hypofluorite to give 7-trifluoromethyl-3-fluoro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one whose measured mass spectrum was m/c 336.0859; Calculated for C17H12ON2F4 : 336.0885.
Workup
- customThe filtrate was evaporated
- dissolutionthe residue was dissolved in CFCl3
- customthe CFCl3 was removed by evaporation
Sources & evidence
- ORD record
- ord-dcdd730112874f8e872c9b750fd5555c
- Source dataset
- uspto-grants-1980_07
- Patent number
- US04215044
Reaction notes
Loading…